Immix Biopharma (IMMX) Change in Cash (2021 - 2026)
Immix Biopharma (IMMX) posted Change in Cash of -$14.7 million for Q1 2026, down 118.82% sequentially from $78.0 million in Q4 2025, and down 733.6% YoY from $2.3 million in Q1 2025.
Immix Biopharma (IMMX) Change in Cash (2021 - 2026) Analysis & Trends
Immix Biopharma has reported Change in Cash for 6 years, with the latest figure at -$14.7 million in Q1 2026.
- Quarterly Change in Cash fell 733.6% year-over-year to -$14.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.3 million (up 572.67% YoY) and the FY2025 annual result came in at $76.2 million, up 44187.46% from the prior year.
- Change in Cash slipped to -$14.7 million in Q1 2026 per IMMX's latest filing, from $78.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $78.0 million in Q4 2025 and troughed at -$14.7 million in Q1 2026.
- A 5-year average of $3.6 million and a median of -$1.8 million in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2025: Change in Cash plunged 1946.43% in 2022, then soared 3982.61% in 2025.
- Over 5 years, Change in Cash stood at -$3.5 million in 2022, then surged by 40.44% to -$2.1 million in 2023, then grew by 3.1% to -$2.0 million in 2024, then jumped by 3982.61% to $78.0 million in 2025, then slumped by 118.82% to -$14.7 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$14.7 million, $78.0 million, and $4.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Immix Biopharma | 784.75 Mn | 784.75 Mn | - | 146.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 146.24 Mn |
| Mar 31, 2026 | -14.68 Mn |
| Dec 31, 2025 | 77.98 Mn |
| Sep 30, 2025 | 4.31 Mn |
| Jun 30, 2025 | -4.28 Mn |
| Mar 31, 2025 | -1.76 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Sep 30, 2024 | -4.28 Mn |
| Jun 30, 2024 | -5.34 Mn |
| Mar 31, 2024 | 11.81 Mn |
| Dec 31, 2023 | -2.07 Mn |
| Sep 30, 2023 | 6.93 Mn |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | -1.97 Mn |
| Dec 31, 2022 | -3.48 Mn |
| Sep 30, 2022 | -1.49 Mn |
| Jun 30, 2022 | -658,333.00 |
| Mar 31, 2022 | 1.42 Mn |
| Dec 31, 2021 | 17.61 Mn |
| Sep 30, 2021 | -72,606.00 |